Suchergebnisse - Frattini, M
- Treffer 1 - 12 von 12
-
1
-
2
-
3
Reply: Do we need biopsies of metastases for colorectal cancer patients? von Frattini, M, Molinari, F, Saletti, P, Mazzucchelli, L
Veröffentlicht 2009Text -
4
-
5
-
6
-
7
-
8
Differing deregulation of EGFR and downstream proteins in primary colorectal cancer and related metastatic sites may be clinically relevant von Molinari, F, Martin, V, Saletti, P, De Dosso, S, Spitale, A, Camponovo, A, Bordoni, A, Crippa, S, Mazzucchelli, L, Frattini, M
Veröffentlicht 2009Text -
9
-
10
Mutation analysis of the EGFR gene and downstream signalling pathway in histologic samples of malignant pleural mesothelioma von Mezzapelle, R, Miglio, U, Rena, O, Paganotti, A, Allegrini, S, Antona, J, Molinari, F, Frattini, M, Monga, G, Alabiso, O, Boldorini, R
Veröffentlicht 2013Text -
11
HER2 gene copy number status may influence clinical efficacy to anti-EGFR monoclonal antibodies in metastatic colorectal cancer patients von Martin, V, Landi, L, Molinari, F, Fountzilas, G, Geva, R, Riva, A, Saletti, P, De Dosso, S, Spitale, A, Tejpar, S, Kalogeras, K T, Mazzucchelli, L, Frattini, M, Cappuzzo, F
Veröffentlicht 2013Text -
12
Prognostic and predictive value of TOPK stratified by KRAS and BRAF gene alterations in sporadic, hereditary and metastatic colorectal cancer patients von Zlobec, I, Molinari, F, Kovac, M, Bihl, M P, Altermatt, H J, Diebold, J, Frick, H, Germer, M, Horcic, M, Montani, M, Singer, G, Yurtsever, H, Zettl, A, Terracciano, L, Mazzucchelli, L, Saletti, P, Frattini, M, Heinimann, K, Lugli, A
Veröffentlicht 2010Text